| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/17/2009 | US7504111 Protein from gonococcus (Neisseria gonorrhoeae), including a specific amino acid sequence; antigens for vaccines, immunogenic compositions, and/or diagnostics; useful for distinguishing between gonococcus and meningococcus |
| 03/17/2009 | US7504108 Polypeptides; immunogenic compositions; generating immune responses; kits |
| 03/17/2009 | US7504106 Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis |
| 03/17/2009 | US7504104 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens |
| 03/17/2009 | US7504103 Targetting slow-growing, relatively mutationally-spared cancer; one-step genetic switches; antiproliferative agents; magnetic resonance imaging |
| 03/17/2009 | US7504089 Cyanine dyes |
| 03/17/2009 | US7504072 Biopolymeric array scanning devices that focus on the far side of an array and methods for using the same |
| 03/17/2009 | US7504068 Apparatus for enhanced evanescent field exposure in an optical fiber resonator for spectroscopic detection and measurement of trace species |
| 03/17/2009 | CA2598247C Method for providing a hardenable mixture of cement and fly ash having a predicted compressive strength |
| 03/17/2009 | CA2493558C Methods for detecting or assaying virus |
| 03/17/2009 | CA2467775C Electrodes, methods, apparatuses comprising micro-electrode arrays |
| 03/17/2009 | CA2309599C Improvements in or relating to displacement assays |
| 03/17/2009 | CA2307603C Method and apparatus for measuring use of a substrate in a microbially catalysed reaction |
| 03/17/2009 | CA2191895C Toxin assay |
| 03/17/2009 | CA2140278C Enriching and identyfing fetal cells in maternal blood for in situ hybridization |
| 03/12/2009 | WO2009033178A1 Copy number variation determination, methods and systems |
| 03/12/2009 | WO2009033163A2 Borrelia diagnostics and screening methods |
| 03/12/2009 | WO2009033156A2 Methods and applications for target quantification |
| 03/12/2009 | WO2009033121A2 Molecules and methods for treatment and detection of diabetes |
| 03/12/2009 | WO2009033094A2 Antibodies and related molecules that bind to 24p4c12 proteins |
| 03/12/2009 | WO2009033056A1 Reusable detection surfaces and methods of using same |
| 03/12/2009 | WO2009033055A1 Methods and kits for identification of anti-excitotoxic compounds |
| 03/12/2009 | WO2009033050A1 Diagnostic and therapeutic uses of augmenter of liver regeneration in inflammatory conditions |
| 03/12/2009 | WO2009033041A1 Egg micro-crack detection systems |
| 03/12/2009 | WO2009033011A1 Use of secretor, lewis and sialyl antigen levels as predictors for disease |
| 03/12/2009 | WO2009032914A2 Method for measuring neurotransmitters in vivo |
| 03/12/2009 | WO2009032904A1 Probe and method for obtaining three-dimensional compositional maps of a biological sample |
| 03/12/2009 | WO2009032827A2 Electroporative flow cytometry |
| 03/12/2009 | WO2009032760A2 Electrochmical sensor and method for manufacturing |
| 03/12/2009 | WO2009032727A1 Docking pose selection optimization via nmr chemical shift perturbation analysis |
| 03/12/2009 | WO2009032722A1 Carbamylated proteins and risk of cardiovascular disease |
| 03/12/2009 | WO2009032716A1 Identifying molecules that modulate protein- protein interactions using protease activated reporters |
| 03/12/2009 | WO2009032712A2 Method and system for moving requested files from one storage location to another |
| 03/12/2009 | WO2009032650A1 Method of fluid control in medical diagnostic media |
| 03/12/2009 | WO2009032456A2 Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state |
| 03/12/2009 | WO2009032422A1 Polymer concentration monitoring system and use thereof |
| 03/12/2009 | WO2009032401A1 Analyte detection via binding molecule-associated enzyme assay |
| 03/12/2009 | WO2009032319A1 Calibrated rpma assay |
| 03/12/2009 | WO2009032297A2 Device for measuring concentrations of constituents of tear sample |
| 03/12/2009 | WO2009032292A1 Methods for diagnosing and treating cancers |
| 03/12/2009 | WO2009032288A1 Methods for predicting embryo viability |
| 03/12/2009 | WO2009032236A1 Fluorescence resonance energy transfer detection with nanoparticles |
| 03/12/2009 | WO2009032205A2 Carbon measurement in aqueous samples using oxidation at elevated temperatures and pressures |
| 03/12/2009 | WO2009032127A1 Two-dimensional control of electrochemical surface potentials |
| 03/12/2009 | WO2009032094A1 Web thickness measurement device |
| 03/12/2009 | WO2009031969A1 Device and method for determining the erythrocyte sedimentation rate in a blood sample |
| 03/12/2009 | WO2009031804A2 Multi-functional polymeric layers and its uses |
| 03/12/2009 | WO2009031761A1 Biosensor and readout meter |
| 03/12/2009 | WO2009031678A1 Method of concentrating human mesenchymal stem cells |
| 03/12/2009 | WO2009031636A1 Blood sugar measuring device |
| 03/12/2009 | WO2009031366A1 Blood examination apparatus |
| 03/12/2009 | WO2009031351A1 Method of detecting viral antigen and kit for detecting viral antigen |
| 03/12/2009 | WO2009031314A1 Blood analysis device |
| 03/12/2009 | WO2009031274A1 Measuring chip |
| 03/12/2009 | WO2009031228A1 Method of detecting viral antigen and kit for detecting viral antigen |
| 03/12/2009 | WO2009031049A2 Reagents and methods for the determination of pk/adme-tox characteristics of new chemical entities and of drug candidates |
| 03/12/2009 | WO2009031045A2 Anti-chikungunya monoclonal antibodies and uses thereof |
| 03/12/2009 | WO2009030978A2 Conformers of bacterial adhesins |
| 03/12/2009 | WO2009030957A1 Apparatus and method |
| 03/12/2009 | WO2009030908A2 Thermal control apparatus for chemical and biochemical reactions |
| 03/12/2009 | WO2009030884A2 Mannosylated butyrophilin tumour markers |
| 03/12/2009 | WO2009030872A1 Materials and methods for the treatment of hepatitis c |
| 03/12/2009 | WO2009030819A1 Luminescent lanthanide (iii) chelates, chelating agents and conjugates derived thereof |
| 03/12/2009 | WO2009030735A1 Method of determination of pdh activity and imaging media for use in said method |
| 03/12/2009 | WO2009030616A1 Test strip container |
| 03/12/2009 | WO2009030482A1 In vitro model for inflammatory diseases of the gut mucosa |
| 03/12/2009 | WO2009030456A1 Method for assaying sepsis in humans |
| 03/12/2009 | WO2009030394A1 Method for the production of a biosensor arrangement |
| 03/12/2009 | WO2009030296A1 Method and device for determining the chemical oxygen requirement of water or waste water |
| 03/12/2009 | WO2009030240A2 Method of determining functional deficiencies in the complement system |
| 03/12/2009 | WO2009030226A2 Marker sequences for rheumatoid arthritis and use thereof |
| 03/12/2009 | WO2009030225A2 Marker sequences for multiple sclerosis and use thereof |
| 03/12/2009 | WO2009030192A1 Indirect determination of the waste gas rate for metallurgical processes |
| 03/12/2009 | WO2009030051A1 Quantification of changes in the degree of order of cellular and viral membranes and applications to diagnosis, treatment and drug screening |
| 03/12/2009 | WO2009030029A1 Method of using tumour rna integrity to measure response to chemotherapy in cancer patients |
| 03/12/2009 | WO2009029971A1 Method for diagnosing the metabolic syndrome (ms) |
| 03/12/2009 | WO2009029964A2 Sensory pigments used on food, packaging, paper and pharmaceutical and electronic products |
| 03/12/2009 | WO2009018478A3 Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
| 03/12/2009 | WO2009018298A3 Method and composition for forming a uniform layer on a substrate |
| 03/12/2009 | WO2009015263A3 Methods for characterizing cell proximity |
| 03/12/2009 | WO2009014563A3 Continuous monitor for cyanide and cyanogen blood agent detection in water |
| 03/12/2009 | WO2009014390A3 Microfluidic sensor complex structure |
| 03/12/2009 | WO2009014379A3 Chip for analyzing fluids |
| 03/12/2009 | WO2009011770A3 Compositions and methods for diagnosing and assesing inflammatory myopathies |
| 03/12/2009 | WO2009011500A3 Methods for decreasing false signals in immunoassay to detect a multimeric form from a monomeric form of multimer-forming polypeptides |
| 03/12/2009 | WO2009010885A3 Use of cd200 as a mesenchymal stem cells marker |
| 03/12/2009 | WO2009007844A3 Breathalyzer test device |
| 03/12/2009 | WO2009006637A3 Mouth alcohol tester |
| 03/12/2009 | WO2009004340A3 Identification of ectopic pregnancies |
| 03/12/2009 | WO2009004216A3 Method for a vehicle fuel circuit |
| 03/12/2009 | WO2009004142A8 Method for fixing compounds comprising peptide bonds, such as proteins, to a microsystem, and microsystem incorporating these compounds |
| 03/12/2009 | WO2008157689A9 Methods of nucleic acid amplification analysis |
| 03/12/2009 | WO2008156865A3 Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease |
| 03/12/2009 | WO2008153543A3 Fluorescent mouse model |
| 03/12/2009 | WO2008152528A3 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications |
| 03/12/2009 | WO2008151032A3 Arrays and methods comprising m. smithii gene products |
| 03/12/2009 | WO2008143890A3 Biomarkers for septic shock patients |
| 03/12/2009 | WO2008136861A3 Inactivated and dried biological preparations |
| 03/12/2009 | WO2008133645A3 Combination vaccine for prevention of tularemia |
| 03/12/2009 | WO2008132167A3 Diagnostic, prognostic and/or predictive indicators of breast cancer |